ArticleScientific reports2025
Trends and gender disparities in the burden of rheumatoid arthritis in Pakistan from 1990 to 2021.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rheumatoid arthritis (RA) significantly drives global morbidity and mortality, yet its evolving impact in low- and middle-income countries remains underexplored. This study harnesses extensive global burden of disease (GBD) data to delineate the temporal trends of RA burden in the Islamic Republic of Pakistan from 1990 to 2021, examine its association with socio-demographic development, and forecast future trajectories through 2036. This retrospective epidemiological study quantified RA disease metrics in Pakistan through GBD data interrogation. Joinpoint regression modeling delineated temporal trajectories, calculating average annual percent change (AAPC) with 95% confidence intervals (CIs). Spearman's rank correlation assessed the relationship between socio-demographic index (SDI) values and age-standardized rates (ASRs) of RA across 204 regions. A Bayesian age-period-cohort (BAPC) model was employed to project RA burden trends in Pakistan from 2022 to 2036. Stratified comparative assessments revealed age- and sex-specific demographic disparities. Although age-standardized incidence rate (ASIR) and age-standardized prevalence rate (ASPR) exhibited modest declines (AAPC: -0.10% and - 0.09%, respectively), the absolute numbers of incident and prevalent RA cases increased markedly-from 8,606 to 19,454 and from 134,628 to 318,963, respectively-between 1990 and 2021. Mortality rates showed a slight upward trend (AAPC: 0.35%), with total deaths rising from 478 to 1,006, while Disability-adjusted life years (DALYs) nearly doubled, increasing from 27,314 to 62,774. Age-specific analyses revealed peak incidence among younger individuals (20-24 years) and higher mortality and DALYs among older populations, particularly those aged 75 and above. Additionally, females consistently experienced a greater burden across all metrics compared to males. SDI exhibited significant positive correlations with ASIR (r = 0.42), ASPR (r = 0.47), age-standardized mortality rate (ASMR) (r = 0.32), and age-standardized DALYs rate (ASDR) (r = 0.46; all p < 0.001), indicating that higher socio-demographic development was associated with a greater documented RA burden. BAPC projections forecast a gradual decline in age-standardized RA rates through 2036, although absolute case numbers are expected to remain high owing to population growth and demographic aging. The RA burden in Pakistan has escalated over the past three decades, with higher-SDI regions demonstrating disproportionately greater age-standardized rates and documented cases. Despite anticipated per-capita declines in RA incidence, prevalence, mortality, and DALYs by 2036, demographic shifts will likely sustain a substantial absolute burden. These findings emphasize the necessity of precise public health measures to advance early diagnosis, optimize disease management, and reinforce prevention-particularly in rapidly developing areas and among high-risk groups such as women and the elderly.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.